Literature DB >> 8042617

Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody.

J Matsuda1, N Saitoh, K Gohchi, M Gotoh, M Tsukamoto.   

Abstract

We investigated anti-annexin V antibody (aANX) in patients with systemic lupus erythematosus (SLE), and correlated to positivity with lupus anticoagulant (LA)/anticardiolipin antibody (aCL). aANX was positive in 12/47 SLE patients (26%), including 7 with beta 2-glycoprotein 1 (GPI)-dependent aANX. The positivity of aANX was higher in patients with aCL (19%) and LA/aCL (50%) than in those without LA/aCL (10%). From these results, it is concluded that aANX is an autoantibody closely related to LA/aCL, and can be a possible new risk marker for thrombosis.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8042617     DOI： 10.1002/ajh.2830470112

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


  14 in total

Review 1.  Testing for and clinical significance of anticardiolipin antibodies.

Authors:  S W Reddel; S A Krilis
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

Review 2.  Antiphospholipid syndrome: multiple mechanisms.

Authors:  C G Mackworth-Young
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

3.  Annexin V autoantibodies in rheumatoid arthritis.

Authors:  M I Rodríguez-García; J A Fernández; A Rodríguez; M P Fernández; C Gutierrez; J C Torre-Alonso
Journal:  Ann Rheum Dis       Date:  1996-12       Impact factor: 19.103

4.  Evaluation of the clinical relevance of anti-annexin-A5 antibodies in Chinese patients with antiphospholipid syndrome.

Authors:  Shulan Zhang; Ziyan Wu; Jing Li; Xiaoting Wen; Liubing Li; Wen Zhang; Jiuliang Zhao; Fengchun Zhang; Yongzhe Li
Journal:  Clin Rheumatol       Date:  2016-12-21       Impact factor: 2.980

Review 5.  Anti-phospholipid antibodies (aPL) and apoptosis: prothrombin-dependent aPL as a paradigm for phospholipid-dependent interactions with apoptotic cells.

Authors:  Joyce Rauch; Paolo D'Agnillo; Rebecca Subang; Jerrold S Levine
Journal:  Thromb Res       Date:  2004       Impact factor: 3.944

6.  Gene-expression patterns predict phenotypes of immune-mediated thrombosis.

Authors:  Anil Potti; Andrea Bild; Holly K Dressman; Deborah A Lewis; Joseph R Nevins; Thomas L Ortel
Journal:  Blood       Date:  2005-11-01       Impact factor: 22.113

7.  Antiannexin V autoantibody in thrombophilic Behçet's disease.

Authors:  H Aslan; S Pay; F Gok; Y Baykal; M I Yilmaz; A Sengul; H I Aydin
Journal:  Rheumatol Int       Date:  2003-12-05       Impact factor: 2.631

8.  Cross-reactivity between annexin A2 and Beta-2-glycoprotein I in animal models of antiphospholipid syndrome.

Authors:  R Weiss; A Bitton; L Nahary; M T Arango; I Benhar; M Blank; Y Shoenfeld; J Chapman
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

9.  Anti-annexin V antibodies in Takayasu's arteritis: prevalence and relationship with disease activity.

Authors:  N K Tripathy; N Sinha; S Nityanand
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

10.  Single-step autoantibody profiling in antiphospholipid syndrome using a multi-line dot assay.

Authors:  Karl Egerer; Dirk Roggenbuck; Thomas Büttner; Barbara Lehmann; Annushka Kohn; Philipp von Landenberg; Rico Hiemann; Eugen Feist; Gerd-Rüdiger Burmester; Thomas Dörner
Journal:  Arthritis Res Ther       Date:  2011-07-21       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.